IBDEI03D ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8044,1,1,0)
;;=1^COMPREHENSIVE, MOD COMPLEX
;;^UTILITY(U,$J,358.3,8044,1,2,0)
;;=2^99344
;;^UTILITY(U,$J,358.3,8045,0)
;;=99345^^44^414^5
;;^UTILITY(U,$J,358.3,8045,1,0)
;;=^358.31IA^2^2
;;^UTILITY(U,$J,358.3,8045,1,1,0)
;;=1^COMPREHENSIVE, HIGH COMPLEX
;;^UTILITY(U,$J,358.3,8045,1,2,0)
;;=2^99345
;;^UTILITY(U,$J,358.3,8046,0)
;;=99347^^44^415^1
;;^UTILITY(U,$J,358.3,8046,1,0)
;;=^358.31IA^2^2
;;^UTILITY(U,$J,358.3,8046,1,1,0)
;;=1^PROBLEM FOCUSED VISIT
;;^UTILITY(U,$J,358.3,8046,1,2,0)
;;=2^99347
;;^UTILITY(U,$J,358.3,8047,0)
;;=99348^^44^415^2
;;^UTILITY(U,$J,358.3,8047,1,0)
;;=^358.31IA^2^2
;;^UTILITY(U,$J,358.3,8047,1,1,0)
;;=1^EXPANDED PROBLEM FOCUSED
;;^UTILITY(U,$J,358.3,8047,1,2,0)
;;=2^99348
;;^UTILITY(U,$J,358.3,8048,0)
;;=99349^^44^415^3
;;^UTILITY(U,$J,358.3,8048,1,0)
;;=^358.31IA^2^2
;;^UTILITY(U,$J,358.3,8048,1,1,0)
;;=1^DETAILED VISIT
;;^UTILITY(U,$J,358.3,8048,1,2,0)
;;=2^99349
;;^UTILITY(U,$J,358.3,8049,0)
;;=99350^^44^415^4
;;^UTILITY(U,$J,358.3,8049,1,0)
;;=^358.31IA^2^2
;;^UTILITY(U,$J,358.3,8049,1,1,0)
;;=1^COMPREHENSIVE VISIT
;;^UTILITY(U,$J,358.3,8049,1,2,0)
;;=2^99350
;;^UTILITY(U,$J,358.3,8050,0)
;;=99339^^44^415^5
;;^UTILITY(U,$J,358.3,8050,1,0)
;;=^358.31IA^2^2
;;^UTILITY(U,$J,358.3,8050,1,1,0)
;;=1^Suprv Home Care or ALF 15-29 Min per Month
;;^UTILITY(U,$J,358.3,8050,1,2,0)
;;=2^99339
;;^UTILITY(U,$J,358.3,8051,0)
;;=99340^^44^415^6
;;^UTILITY(U,$J,358.3,8051,1,0)
;;=^358.31IA^2^2
;;^UTILITY(U,$J,358.3,8051,1,1,0)
;;=1^Suprv Home Care or ALF 30+ Min per Month
;;^UTILITY(U,$J,358.3,8051,1,2,0)
;;=2^99340
;;^UTILITY(U,$J,358.3,8052,0)
;;=B18.2^^45^416^40
;;^UTILITY(U,$J,358.3,8052,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8052,1,3,0)
;;=3^Hepatitis C,Chr
;;^UTILITY(U,$J,358.3,8052,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,8052,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,8053,0)
;;=E11.9^^45^416^25
;;^UTILITY(U,$J,358.3,8053,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8053,1,3,0)
;;=3^Diabetes Type 2
;;^UTILITY(U,$J,358.3,8053,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,8053,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,8054,0)
;;=E11.40^^45^416^23
;;^UTILITY(U,$J,358.3,8054,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8054,1,3,0)
;;=3^DM Type 2 w/ Neuropathy
;;^UTILITY(U,$J,358.3,8054,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,8054,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,8055,0)
;;=E78.2^^45^416^41
;;^UTILITY(U,$J,358.3,8055,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8055,1,3,0)
;;=3^Hyperlipidemia,Mixed
;;^UTILITY(U,$J,358.3,8055,1,4,0)
;;=4^E78.2
;;^UTILITY(U,$J,358.3,8055,2)
;;=^78424
;;^UTILITY(U,$J,358.3,8056,0)
;;=E78.5^^45^416^42
;;^UTILITY(U,$J,358.3,8056,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8056,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,8056,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,8056,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,8057,0)
;;=E66.3^^45^416^59
;;^UTILITY(U,$J,358.3,8057,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8057,1,3,0)
;;=3^Overweight
;;^UTILITY(U,$J,358.3,8057,1,4,0)
;;=4^E66.3
;;^UTILITY(U,$J,358.3,8057,2)
;;=^5002830
;;^UTILITY(U,$J,358.3,8058,0)
;;=F17.200^^45^416^52
;;^UTILITY(U,$J,358.3,8058,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8058,1,3,0)
;;=3^Nicotine Dependence,Unspec
;;^UTILITY(U,$J,358.3,8058,1,4,0)
;;=4^F17.200
;;^UTILITY(U,$J,358.3,8058,2)
;;=^5003360
;;^UTILITY(U,$J,358.3,8059,0)
;;=G43.909^^45^416^50
;;^UTILITY(U,$J,358.3,8059,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8059,1,3,0)
;;=3^Migraine,Unspec
;;^UTILITY(U,$J,358.3,8059,1,4,0)
;;=4^G43.909
;;^UTILITY(U,$J,358.3,8059,2)
;;=^5003909
;;^UTILITY(U,$J,358.3,8060,0)
;;=H91.93^^45^416^36
;;^UTILITY(U,$J,358.3,8060,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8060,1,3,0)
;;=3^Hearing Loss,Bilateral
;;^UTILITY(U,$J,358.3,8060,1,4,0)
;;=4^H91.93
;;^UTILITY(U,$J,358.3,8060,2)
;;=^5006944
;;^UTILITY(U,$J,358.3,8061,0)
;;=I10.^^45^416^43
;;^UTILITY(U,$J,358.3,8061,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8061,1,3,0)
;;=3^Hypertension
;;^UTILITY(U,$J,358.3,8061,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,8061,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,8062,0)
;;=I50.9^^45^416^19
;;^UTILITY(U,$J,358.3,8062,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8062,1,3,0)
;;=3^Congestive Heart Failure,Unspec
;;^UTILITY(U,$J,358.3,8062,1,4,0)
;;=4^I50.9
;;^UTILITY(U,$J,358.3,8062,2)
;;=^5007251
;;^UTILITY(U,$J,358.3,8063,0)
;;=I67.89^^45^416^18
;;^UTILITY(U,$J,358.3,8063,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8063,1,3,0)
;;=3^Cerebrovascular Disease,Oth
;;^UTILITY(U,$J,358.3,8063,1,4,0)
;;=4^I67.89
;;^UTILITY(U,$J,358.3,8063,2)
;;=^5007388
;;^UTILITY(U,$J,358.3,8064,0)
;;=J45.909^^45^416^4
;;^UTILITY(U,$J,358.3,8064,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8064,1,3,0)
;;=3^Asthma,Unspec,Uncomplicated
;;^UTILITY(U,$J,358.3,8064,1,4,0)
;;=4^J45.909
;;^UTILITY(U,$J,358.3,8064,2)
;;=^5008256
;;^UTILITY(U,$J,358.3,8065,0)
;;=J44.9^^45^416^16
;;^UTILITY(U,$J,358.3,8065,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8065,1,3,0)
;;=3^COPD,Unspec
;;^UTILITY(U,$J,358.3,8065,1,4,0)
;;=4^J44.9
;;^UTILITY(U,$J,358.3,8065,2)
;;=^5008241
;;^UTILITY(U,$J,358.3,8066,0)
;;=K21.9^^45^416^31
;;^UTILITY(U,$J,358.3,8066,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8066,1,3,0)
;;=3^GERD w/o Esophagitis
;;^UTILITY(U,$J,358.3,8066,1,4,0)
;;=4^K21.9
;;^UTILITY(U,$J,358.3,8066,2)
;;=^5008505
;;^UTILITY(U,$J,358.3,8067,0)
;;=N40.1^^45^416^29
;;^UTILITY(U,$J,358.3,8067,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8067,1,3,0)
;;=3^Enlarged Prostate w/ LUTS
;;^UTILITY(U,$J,358.3,8067,1,4,0)
;;=4^N40.1
;;^UTILITY(U,$J,358.3,8067,2)
;;=^5015690
;;^UTILITY(U,$J,358.3,8068,0)
;;=L03.818^^45^416^17
;;^UTILITY(U,$J,358.3,8068,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8068,1,3,0)
;;=3^Cellulitis,Oth Sites
;;^UTILITY(U,$J,358.3,8068,1,4,0)
;;=4^L03.818
;;^UTILITY(U,$J,358.3,8068,2)
;;=^5009064
;;^UTILITY(U,$J,358.3,8069,0)
;;=G47.33^^45^416^77
;;^UTILITY(U,$J,358.3,8069,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8069,1,3,0)
;;=3^Sleep Apnea,Obstructive
;;^UTILITY(U,$J,358.3,8069,1,4,0)
;;=4^G47.33
;;^UTILITY(U,$J,358.3,8069,2)
;;=^332763
;;^UTILITY(U,$J,358.3,8070,0)
;;=R73.01^^45^416^46
;;^UTILITY(U,$J,358.3,8070,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8070,1,3,0)
;;=3^Impaired Fasting Glucose
;;^UTILITY(U,$J,358.3,8070,1,4,0)
;;=4^R73.01
;;^UTILITY(U,$J,358.3,8070,2)
;;=^5019561
;;^UTILITY(U,$J,358.3,8071,0)
;;=R74.8^^45^416^1
;;^UTILITY(U,$J,358.3,8071,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8071,1,3,0)
;;=3^Abnormal Levels of Serum Enzymes
;;^UTILITY(U,$J,358.3,8071,1,4,0)
;;=4^R74.8
;;^UTILITY(U,$J,358.3,8071,2)
;;=^5019566
;;^UTILITY(U,$J,358.3,8072,0)
;;=R03.0^^45^416^27
;;^UTILITY(U,$J,358.3,8072,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8072,1,3,0)
;;=3^Elevated BP Reading w/o Diagnosis of HTN
;;^UTILITY(U,$J,358.3,8072,1,4,0)
;;=4^R03.0
;;^UTILITY(U,$J,358.3,8072,2)
;;=^5019171
;;^UTILITY(U,$J,358.3,8073,0)
;;=Z91.19^^45^416^53
;;^UTILITY(U,$J,358.3,8073,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8073,1,3,0)
;;=3^Noncompliance w/ Medical Treatment/Regimen
;;^UTILITY(U,$J,358.3,8073,1,4,0)
;;=4^Z91.19
;;^UTILITY(U,$J,358.3,8073,2)
;;=^5063618
;;^UTILITY(U,$J,358.3,8074,0)
;;=E66.01^^45^416^54
;;^UTILITY(U,$J,358.3,8074,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8074,1,3,0)
;;=3^Obesity,Morbid
;;^UTILITY(U,$J,358.3,8074,1,4,0)
;;=4^E66.01
;;^UTILITY(U,$J,358.3,8074,2)
;;=^5002826
;;^UTILITY(U,$J,358.3,8075,0)
;;=F43.11^^45^416^61
;;^UTILITY(U,$J,358.3,8075,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8075,1,3,0)
;;=3^PTSD,Acute
;;^UTILITY(U,$J,358.3,8075,1,4,0)
;;=4^F43.11
;;^UTILITY(U,$J,358.3,8075,2)
;;=^5003571
;;^UTILITY(U,$J,358.3,8076,0)
;;=F43.12^^45^416^62
;;^UTILITY(U,$J,358.3,8076,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8076,1,3,0)
;;=3^PTSD,Chronic
;;^UTILITY(U,$J,358.3,8076,1,4,0)
;;=4^F43.12
;;^UTILITY(U,$J,358.3,8076,2)
;;=^5003572
;;^UTILITY(U,$J,358.3,8077,0)
;;=I25.119^^45^416^5
;;^UTILITY(U,$J,358.3,8077,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8077,1,3,0)
;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
;;^UTILITY(U,$J,358.3,8077,1,4,0)
;;=4^I25.119
;;^UTILITY(U,$J,358.3,8077,2)
;;=^5007111
;;^UTILITY(U,$J,358.3,8078,0)
;;=I25.10^^45^416^6
;;^UTILITY(U,$J,358.3,8078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8078,1,3,0)
;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
;;^UTILITY(U,$J,358.3,8078,1,4,0)
;;=4^I25.10
;;^UTILITY(U,$J,358.3,8078,2)
;;=^5007107
;;^UTILITY(U,$J,358.3,8079,0)
;;=F17.219^^45^416^51
;;^UTILITY(U,$J,358.3,8079,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8079,1,3,0)
;;=3^Nicotine Dependence,Cigarettes
;;^UTILITY(U,$J,358.3,8079,1,4,0)
;;=4^F17.219
;;^UTILITY(U,$J,358.3,8079,2)
;;=^5003369
;;^UTILITY(U,$J,358.3,8080,0)
;;=Z51.5^^45^416^64
;;^UTILITY(U,$J,358.3,8080,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8080,1,3,0)
;;=3^Palliative Care Encounter
;;^UTILITY(U,$J,358.3,8080,1,4,0)
;;=4^Z51.5
;;^UTILITY(U,$J,358.3,8080,2)
;;=^5063063
;;^UTILITY(U,$J,358.3,8081,0)
;;=Z23.^^45^416^28
;;^UTILITY(U,$J,358.3,8081,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8081,1,3,0)
;;=3^Encounter for Immunization(s)
;;^UTILITY(U,$J,358.3,8081,1,4,0)
;;=4^Z23.
;;^UTILITY(U,$J,358.3,8081,2)
;;=^5062795
;;^UTILITY(U,$J,358.3,8082,0)
;;=E11.65^^45^416^20
;;^UTILITY(U,$J,358.3,8082,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8082,1,3,0)
;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,8082,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,8082,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,8083,0)
;;=E11.649^^45^416^21
;;^UTILITY(U,$J,358.3,8083,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8083,1,3,0)
;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,8083,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,8083,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,8084,0)
;;=I16.0^^45^416^44
;;^UTILITY(U,$J,358.3,8084,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8084,1,3,0)
;;=3^Hypertensive Urgency
;;^UTILITY(U,$J,358.3,8084,1,4,0)
;;=4^I16.0
;;^UTILITY(U,$J,358.3,8084,2)
;;=^8133013
;;^UTILITY(U,$J,358.3,8085,0)
;;=H54.8^^45^416^47
;;^UTILITY(U,$J,358.3,8085,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8085,1,3,0)
;;=3^Legal Blindness,USA Definition
;;^UTILITY(U,$J,358.3,8085,1,4,0)
;;=4^H54.8
;;^UTILITY(U,$J,358.3,8085,2)
;;=^5006369
;;^UTILITY(U,$J,358.3,8086,0)
;;=F10.10^^45^416^2
;;^UTILITY(U,$J,358.3,8086,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8086,1,3,0)
;;=3^Alcohol Abuse,Uncomplicated
;;^UTILITY(U,$J,358.3,8086,1,4,0)
;;=4^F10.10
;;^UTILITY(U,$J,358.3,8086,2)
;;=^5003068
;;^UTILITY(U,$J,358.3,8087,0)
;;=J30.9^^45^416^3
;;^UTILITY(U,$J,358.3,8087,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8087,1,3,0)
;;=3^Allergic Rhinitis,Unspec
;;^UTILITY(U,$J,358.3,8087,1,4,0)
;;=4^J30.9
;;^UTILITY(U,$J,358.3,8087,2)
;;=^5008205
;;^UTILITY(U,$J,358.3,8088,0)
;;=I48.0^^45^416^7
;;^UTILITY(U,$J,358.3,8088,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8088,1,3,0)
;;=3^Atrial Fibrillation Paroxysmal (PAF)
;;^UTILITY(U,$J,358.3,8088,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,8088,2)
;;=^90473
;;^UTILITY(U,$J,358.3,8089,0)
;;=N18.1^^45^416^9
;;^UTILITY(U,$J,358.3,8089,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8089,1,3,0)
;;=3^CKD,Stage 1
;;^UTILITY(U,$J,358.3,8089,1,4,0)
;;=4^N18.1
;;^UTILITY(U,$J,358.3,8089,2)
;;=^5015602
;;^UTILITY(U,$J,358.3,8090,0)
;;=N18.2^^45^416^10
;;^UTILITY(U,$J,358.3,8090,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8090,1,3,0)
;;=3^CKD,Stage 2
;;^UTILITY(U,$J,358.3,8090,1,4,0)
;;=4^N18.2
;;^UTILITY(U,$J,358.3,8090,2)
;;=^5015603
;;^UTILITY(U,$J,358.3,8091,0)
;;=N18.4^^45^416^14
;;^UTILITY(U,$J,358.3,8091,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8091,1,3,0)
;;=3^CKD,Stage 4
;;^UTILITY(U,$J,358.3,8091,1,4,0)
;;=4^N18.4
;;^UTILITY(U,$J,358.3,8091,2)
;;=^5015605
;;^UTILITY(U,$J,358.3,8092,0)
;;=N18.5^^45^416^15
;;^UTILITY(U,$J,358.3,8092,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8092,1,3,0)
;;=3^CKD,Stage 5
;;^UTILITY(U,$J,358.3,8092,1,4,0)
;;=4^N18.5
;;^UTILITY(U,$J,358.3,8092,2)
;;=^5015606
;;^UTILITY(U,$J,358.3,8093,0)
;;=N18.6^^45^416^26
;;^UTILITY(U,$J,358.3,8093,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8093,1,3,0)
;;=3^ESRD
;;^UTILITY(U,$J,358.3,8093,1,4,0)
;;=4^N18.6
;;^UTILITY(U,$J,358.3,8093,2)
;;=^303986
;;^UTILITY(U,$J,358.3,8094,0)
;;=E11.22^^45^416^22
;;^UTILITY(U,$J,358.3,8094,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8094,1,3,0)
;;=3^DM Type 2 w/ CKD
;;^UTILITY(U,$J,358.3,8094,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,8094,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,8095,0)
;;=E11.319^^45^416^24
;;^UTILITY(U,$J,358.3,8095,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8095,1,3,0)
;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
;;^UTILITY(U,$J,358.3,8095,1,4,0)
;;=4^E11.319
;;^UTILITY(U,$J,358.3,8095,2)
;;=^5002633
;;^UTILITY(U,$J,358.3,8096,0)
;;=G40.909^^45^416^76
;;^UTILITY(U,$J,358.3,8096,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8096,1,3,0)
;;=3^Seizure Disorder NOS
;;^UTILITY(U,$J,358.3,8096,1,4,0)
;;=4^G40.909
;;^UTILITY(U,$J,358.3,8096,2)
;;=^5003865
;;^UTILITY(U,$J,358.3,8097,0)
;;=N52.9^^45^416^30
;;^UTILITY(U,$J,358.3,8097,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8097,1,3,0)
;;=3^Erectile Dysfuntion,Unspec
;;^UTILITY(U,$J,358.3,8097,1,4,0)
;;=4^N52.9
;;^UTILITY(U,$J,358.3,8097,2)
;;=^5015763
;;^UTILITY(U,$J,358.3,8098,0)
;;=I50.22^^45^416^39
;;^UTILITY(U,$J,358.3,8098,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8098,1,3,0)
;;=3^Heart Failure,Systolic,Chronic
;;^UTILITY(U,$J,358.3,8098,1,4,0)
;;=4^I50.22
;;^UTILITY(U,$J,358.3,8098,2)
;;=^5007241
;;^UTILITY(U,$J,358.3,8099,0)
;;=I50.32^^45^416^37
;;^UTILITY(U,$J,358.3,8099,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8099,1,3,0)
;;=3^Heart Failure,Diastolic,Chronic
;;^UTILITY(U,$J,358.3,8099,1,4,0)
;;=4^I50.32
;;^UTILITY(U,$J,358.3,8099,2)
;;=^5007245
;;^UTILITY(U,$J,358.3,8100,0)
;;=I50.42^^45^416^38
;;^UTILITY(U,$J,358.3,8100,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8100,1,3,0)
;;=3^Heart Failure,Systolic & Diastolic,Chronic
;;^UTILITY(U,$J,358.3,8100,1,4,0)
;;=4^I50.42
;;^UTILITY(U,$J,358.3,8100,2)
;;=^5007249
;;^UTILITY(U,$J,358.3,8101,0)
;;=I13.0^^45^416^32
;;^UTILITY(U,$J,358.3,8101,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8101,1,3,0)
;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,8101,1,4,0)
;;=4^I13.0
;;^UTILITY(U,$J,358.3,8101,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,8102,0)
;;=I13.2^^45^416^33
;;^UTILITY(U,$J,358.3,8102,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8102,1,3,0)
;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
;;^UTILITY(U,$J,358.3,8102,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,8102,2)
;;=^5007070
;;^UTILITY(U,$J,358.3,8103,0)
;;=I13.10^^45^416^34
;;^UTILITY(U,$J,358.3,8103,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8103,1,3,0)
;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,8103,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,8103,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,8104,0)
;;=I13.11^^45^416^35
;;^UTILITY(U,$J,358.3,8104,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8104,1,3,0)
;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
;;^UTILITY(U,$J,358.3,8104,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,8104,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,8105,0)
;;=E03.9^^45^416^45
;;^UTILITY(U,$J,358.3,8105,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8105,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,8105,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,8105,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,8106,0)
;;=C61.^^45^416^49
;;^UTILITY(U,$J,358.3,8106,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8106,1,3,0)
;;=3^Malig Neopl Prostate
;;^UTILITY(U,$J,358.3,8106,1,4,0)
;;=4^C61.
;;^UTILITY(U,$J,358.3,8106,2)
;;=^267239
;;^UTILITY(U,$J,358.3,8107,0)
;;=F11.20^^45^416^55
;;^UTILITY(U,$J,358.3,8107,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8107,1,3,0)
;;=3^Opioid Dependence,Uncomplicated
;;^UTILITY(U,$J,358.3,8107,1,4,0)
;;=4^F11.20
;;^UTILITY(U,$J,358.3,8107,2)
;;=^5003127
;;^UTILITY(U,$J,358.3,8108,0)
;;=M19.90^^45^416^56
;;^UTILITY(U,$J,358.3,8108,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8108,1,3,0)
;;=3^Osteoarthritis,Unspec
;;^UTILITY(U,$J,358.3,8108,1,4,0)
;;=4^M19.90
;;^UTILITY(U,$J,358.3,8108,2)
;;=^5010853
;;^UTILITY(U,$J,358.3,8109,0)
;;=M85.80^^45^416^57
;;^UTILITY(U,$J,358.3,8109,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8109,1,3,0)
;;=3^Osteopenia,Unspec Site
;;^UTILITY(U,$J,358.3,8109,1,4,0)
;;=4^M85.80
;;^UTILITY(U,$J,358.3,8109,2)
;;=^5014473
;;^UTILITY(U,$J,358.3,8110,0)
;;=M81.0^^45^416^58
;;^UTILITY(U,$J,358.3,8110,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8110,1,3,0)
;;=3^Osteoporosis,Age-Related w/o Fx
;;^UTILITY(U,$J,358.3,8110,1,4,0)
;;=4^M81.0
;;^UTILITY(U,$J,358.3,8110,2)
;;=^5013555
;;^UTILITY(U,$J,358.3,8111,0)
;;=I73.9^^45^416^65
;;^UTILITY(U,$J,358.3,8111,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8111,1,3,0)
;;=3^Peripheral Vascular Disease,Unspec
;;^UTILITY(U,$J,358.3,8111,1,4,0)
;;=4^I73.9
;;^UTILITY(U,$J,358.3,8111,2)
;;=^184182
;;^UTILITY(U,$J,358.3,8112,0)
;;=R21.^^45^416^68
;;^UTILITY(U,$J,358.3,8112,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8112,1,3,0)
;;=3^Rash
;;^UTILITY(U,$J,358.3,8112,1,4,0)
;;=4^R21.
;;^UTILITY(U,$J,358.3,8112,2)
;;=^5019283
;;^UTILITY(U,$J,358.3,8113,0)
;;=Z12.11^^45^416^73
;;^UTILITY(U,$J,358.3,8113,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8113,1,3,0)
;;=3^Screening,Colon CA
;;^UTILITY(U,$J,358.3,8113,1,4,0)
;;=4^Z12.11
;;^UTILITY(U,$J,358.3,8113,2)
;;=^5062681
;;^UTILITY(U,$J,358.3,8114,0)
;;=Z12.39^^45^416^71
;;^UTILITY(U,$J,358.3,8114,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8114,1,3,0)
;;=3^Screening,Breast CA
;;^UTILITY(U,$J,358.3,8114,1,4,0)
;;=4^Z12.39
;;^UTILITY(U,$J,358.3,8114,2)
;;=^5062686
;;^UTILITY(U,$J,358.3,8115,0)
;;=Z12.4^^45^416^72
;;^UTILITY(U,$J,358.3,8115,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8115,1,3,0)
;;=3^Screening,Cervical CA
;;^UTILITY(U,$J,358.3,8115,1,4,0)
;;=4^Z12.4
;;^UTILITY(U,$J,358.3,8115,2)
;;=^5062687
;;^UTILITY(U,$J,358.3,8116,0)
;;=Z13.6^^45^416^70
;;^UTILITY(U,$J,358.3,8116,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8116,1,3,0)
;;=3^Screening,AAA
;;^UTILITY(U,$J,358.3,8116,1,4,0)
;;=4^Z13.6
;;^UTILITY(U,$J,358.3,8116,2)
;;=^5062707
;;^UTILITY(U,$J,358.3,8117,0)
;;=Z11.3^^45^416^75
;;^UTILITY(U,$J,358.3,8117,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI03D 19756 printed Sep 23, 2025@19:16:48 Page 2
IBDEI03D ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8044,1,1,0)
+2 ;;=1^COMPREHENSIVE, MOD COMPLEX
+3 ;;^UTILITY(U,$J,358.3,8044,1,2,0)
+4 ;;=2^99344
+5 ;;^UTILITY(U,$J,358.3,8045,0)
+6 ;;=99345^^44^414^5
+7 ;;^UTILITY(U,$J,358.3,8045,1,0)
+8 ;;=^358.31IA^2^2
+9 ;;^UTILITY(U,$J,358.3,8045,1,1,0)
+10 ;;=1^COMPREHENSIVE, HIGH COMPLEX
+11 ;;^UTILITY(U,$J,358.3,8045,1,2,0)
+12 ;;=2^99345
+13 ;;^UTILITY(U,$J,358.3,8046,0)
+14 ;;=99347^^44^415^1
+15 ;;^UTILITY(U,$J,358.3,8046,1,0)
+16 ;;=^358.31IA^2^2
+17 ;;^UTILITY(U,$J,358.3,8046,1,1,0)
+18 ;;=1^PROBLEM FOCUSED VISIT
+19 ;;^UTILITY(U,$J,358.3,8046,1,2,0)
+20 ;;=2^99347
+21 ;;^UTILITY(U,$J,358.3,8047,0)
+22 ;;=99348^^44^415^2
+23 ;;^UTILITY(U,$J,358.3,8047,1,0)
+24 ;;=^358.31IA^2^2
+25 ;;^UTILITY(U,$J,358.3,8047,1,1,0)
+26 ;;=1^EXPANDED PROBLEM FOCUSED
+27 ;;^UTILITY(U,$J,358.3,8047,1,2,0)
+28 ;;=2^99348
+29 ;;^UTILITY(U,$J,358.3,8048,0)
+30 ;;=99349^^44^415^3
+31 ;;^UTILITY(U,$J,358.3,8048,1,0)
+32 ;;=^358.31IA^2^2
+33 ;;^UTILITY(U,$J,358.3,8048,1,1,0)
+34 ;;=1^DETAILED VISIT
+35 ;;^UTILITY(U,$J,358.3,8048,1,2,0)
+36 ;;=2^99349
+37 ;;^UTILITY(U,$J,358.3,8049,0)
+38 ;;=99350^^44^415^4
+39 ;;^UTILITY(U,$J,358.3,8049,1,0)
+40 ;;=^358.31IA^2^2
+41 ;;^UTILITY(U,$J,358.3,8049,1,1,0)
+42 ;;=1^COMPREHENSIVE VISIT
+43 ;;^UTILITY(U,$J,358.3,8049,1,2,0)
+44 ;;=2^99350
+45 ;;^UTILITY(U,$J,358.3,8050,0)
+46 ;;=99339^^44^415^5
+47 ;;^UTILITY(U,$J,358.3,8050,1,0)
+48 ;;=^358.31IA^2^2
+49 ;;^UTILITY(U,$J,358.3,8050,1,1,0)
+50 ;;=1^Suprv Home Care or ALF 15-29 Min per Month
+51 ;;^UTILITY(U,$J,358.3,8050,1,2,0)
+52 ;;=2^99339
+53 ;;^UTILITY(U,$J,358.3,8051,0)
+54 ;;=99340^^44^415^6
+55 ;;^UTILITY(U,$J,358.3,8051,1,0)
+56 ;;=^358.31IA^2^2
+57 ;;^UTILITY(U,$J,358.3,8051,1,1,0)
+58 ;;=1^Suprv Home Care or ALF 30+ Min per Month
+59 ;;^UTILITY(U,$J,358.3,8051,1,2,0)
+60 ;;=2^99340
+61 ;;^UTILITY(U,$J,358.3,8052,0)
+62 ;;=B18.2^^45^416^40
+63 ;;^UTILITY(U,$J,358.3,8052,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,8052,1,3,0)
+66 ;;=3^Hepatitis C,Chr
+67 ;;^UTILITY(U,$J,358.3,8052,1,4,0)
+68 ;;=4^B18.2
+69 ;;^UTILITY(U,$J,358.3,8052,2)
+70 ;;=^5000548
+71 ;;^UTILITY(U,$J,358.3,8053,0)
+72 ;;=E11.9^^45^416^25
+73 ;;^UTILITY(U,$J,358.3,8053,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,8053,1,3,0)
+76 ;;=3^Diabetes Type 2
+77 ;;^UTILITY(U,$J,358.3,8053,1,4,0)
+78 ;;=4^E11.9
+79 ;;^UTILITY(U,$J,358.3,8053,2)
+80 ;;=^5002666
+81 ;;^UTILITY(U,$J,358.3,8054,0)
+82 ;;=E11.40^^45^416^23
+83 ;;^UTILITY(U,$J,358.3,8054,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,8054,1,3,0)
+86 ;;=3^DM Type 2 w/ Neuropathy
+87 ;;^UTILITY(U,$J,358.3,8054,1,4,0)
+88 ;;=4^E11.40
+89 ;;^UTILITY(U,$J,358.3,8054,2)
+90 ;;=^5002644
+91 ;;^UTILITY(U,$J,358.3,8055,0)
+92 ;;=E78.2^^45^416^41
+93 ;;^UTILITY(U,$J,358.3,8055,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,8055,1,3,0)
+96 ;;=3^Hyperlipidemia,Mixed
+97 ;;^UTILITY(U,$J,358.3,8055,1,4,0)
+98 ;;=4^E78.2
+99 ;;^UTILITY(U,$J,358.3,8055,2)
+100 ;;=^78424
+101 ;;^UTILITY(U,$J,358.3,8056,0)
+102 ;;=E78.5^^45^416^42
+103 ;;^UTILITY(U,$J,358.3,8056,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,8056,1,3,0)
+106 ;;=3^Hyperlipidemia,Unspec
+107 ;;^UTILITY(U,$J,358.3,8056,1,4,0)
+108 ;;=4^E78.5
+109 ;;^UTILITY(U,$J,358.3,8056,2)
+110 ;;=^5002969
+111 ;;^UTILITY(U,$J,358.3,8057,0)
+112 ;;=E66.3^^45^416^59
+113 ;;^UTILITY(U,$J,358.3,8057,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,8057,1,3,0)
+116 ;;=3^Overweight
+117 ;;^UTILITY(U,$J,358.3,8057,1,4,0)
+118 ;;=4^E66.3
+119 ;;^UTILITY(U,$J,358.3,8057,2)
+120 ;;=^5002830
+121 ;;^UTILITY(U,$J,358.3,8058,0)
+122 ;;=F17.200^^45^416^52
+123 ;;^UTILITY(U,$J,358.3,8058,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,8058,1,3,0)
+126 ;;=3^Nicotine Dependence,Unspec
+127 ;;^UTILITY(U,$J,358.3,8058,1,4,0)
+128 ;;=4^F17.200
+129 ;;^UTILITY(U,$J,358.3,8058,2)
+130 ;;=^5003360
+131 ;;^UTILITY(U,$J,358.3,8059,0)
+132 ;;=G43.909^^45^416^50
+133 ;;^UTILITY(U,$J,358.3,8059,1,0)
+134 ;;=^358.31IA^4^2
+135 ;;^UTILITY(U,$J,358.3,8059,1,3,0)
+136 ;;=3^Migraine,Unspec
+137 ;;^UTILITY(U,$J,358.3,8059,1,4,0)
+138 ;;=4^G43.909
+139 ;;^UTILITY(U,$J,358.3,8059,2)
+140 ;;=^5003909
+141 ;;^UTILITY(U,$J,358.3,8060,0)
+142 ;;=H91.93^^45^416^36
+143 ;;^UTILITY(U,$J,358.3,8060,1,0)
+144 ;;=^358.31IA^4^2
+145 ;;^UTILITY(U,$J,358.3,8060,1,3,0)
+146 ;;=3^Hearing Loss,Bilateral
+147 ;;^UTILITY(U,$J,358.3,8060,1,4,0)
+148 ;;=4^H91.93
+149 ;;^UTILITY(U,$J,358.3,8060,2)
+150 ;;=^5006944
+151 ;;^UTILITY(U,$J,358.3,8061,0)
+152 ;;=I10.^^45^416^43
+153 ;;^UTILITY(U,$J,358.3,8061,1,0)
+154 ;;=^358.31IA^4^2
+155 ;;^UTILITY(U,$J,358.3,8061,1,3,0)
+156 ;;=3^Hypertension
+157 ;;^UTILITY(U,$J,358.3,8061,1,4,0)
+158 ;;=4^I10.
+159 ;;^UTILITY(U,$J,358.3,8061,2)
+160 ;;=^5007062
+161 ;;^UTILITY(U,$J,358.3,8062,0)
+162 ;;=I50.9^^45^416^19
+163 ;;^UTILITY(U,$J,358.3,8062,1,0)
+164 ;;=^358.31IA^4^2
+165 ;;^UTILITY(U,$J,358.3,8062,1,3,0)
+166 ;;=3^Congestive Heart Failure,Unspec
+167 ;;^UTILITY(U,$J,358.3,8062,1,4,0)
+168 ;;=4^I50.9
+169 ;;^UTILITY(U,$J,358.3,8062,2)
+170 ;;=^5007251
+171 ;;^UTILITY(U,$J,358.3,8063,0)
+172 ;;=I67.89^^45^416^18
+173 ;;^UTILITY(U,$J,358.3,8063,1,0)
+174 ;;=^358.31IA^4^2
+175 ;;^UTILITY(U,$J,358.3,8063,1,3,0)
+176 ;;=3^Cerebrovascular Disease,Oth
+177 ;;^UTILITY(U,$J,358.3,8063,1,4,0)
+178 ;;=4^I67.89
+179 ;;^UTILITY(U,$J,358.3,8063,2)
+180 ;;=^5007388
+181 ;;^UTILITY(U,$J,358.3,8064,0)
+182 ;;=J45.909^^45^416^4
+183 ;;^UTILITY(U,$J,358.3,8064,1,0)
+184 ;;=^358.31IA^4^2
+185 ;;^UTILITY(U,$J,358.3,8064,1,3,0)
+186 ;;=3^Asthma,Unspec,Uncomplicated
+187 ;;^UTILITY(U,$J,358.3,8064,1,4,0)
+188 ;;=4^J45.909
+189 ;;^UTILITY(U,$J,358.3,8064,2)
+190 ;;=^5008256
+191 ;;^UTILITY(U,$J,358.3,8065,0)
+192 ;;=J44.9^^45^416^16
+193 ;;^UTILITY(U,$J,358.3,8065,1,0)
+194 ;;=^358.31IA^4^2
+195 ;;^UTILITY(U,$J,358.3,8065,1,3,0)
+196 ;;=3^COPD,Unspec
+197 ;;^UTILITY(U,$J,358.3,8065,1,4,0)
+198 ;;=4^J44.9
+199 ;;^UTILITY(U,$J,358.3,8065,2)
+200 ;;=^5008241
+201 ;;^UTILITY(U,$J,358.3,8066,0)
+202 ;;=K21.9^^45^416^31
+203 ;;^UTILITY(U,$J,358.3,8066,1,0)
+204 ;;=^358.31IA^4^2
+205 ;;^UTILITY(U,$J,358.3,8066,1,3,0)
+206 ;;=3^GERD w/o Esophagitis
+207 ;;^UTILITY(U,$J,358.3,8066,1,4,0)
+208 ;;=4^K21.9
+209 ;;^UTILITY(U,$J,358.3,8066,2)
+210 ;;=^5008505
+211 ;;^UTILITY(U,$J,358.3,8067,0)
+212 ;;=N40.1^^45^416^29
+213 ;;^UTILITY(U,$J,358.3,8067,1,0)
+214 ;;=^358.31IA^4^2
+215 ;;^UTILITY(U,$J,358.3,8067,1,3,0)
+216 ;;=3^Enlarged Prostate w/ LUTS
+217 ;;^UTILITY(U,$J,358.3,8067,1,4,0)
+218 ;;=4^N40.1
+219 ;;^UTILITY(U,$J,358.3,8067,2)
+220 ;;=^5015690
+221 ;;^UTILITY(U,$J,358.3,8068,0)
+222 ;;=L03.818^^45^416^17
+223 ;;^UTILITY(U,$J,358.3,8068,1,0)
+224 ;;=^358.31IA^4^2
+225 ;;^UTILITY(U,$J,358.3,8068,1,3,0)
+226 ;;=3^Cellulitis,Oth Sites
+227 ;;^UTILITY(U,$J,358.3,8068,1,4,0)
+228 ;;=4^L03.818
+229 ;;^UTILITY(U,$J,358.3,8068,2)
+230 ;;=^5009064
+231 ;;^UTILITY(U,$J,358.3,8069,0)
+232 ;;=G47.33^^45^416^77
+233 ;;^UTILITY(U,$J,358.3,8069,1,0)
+234 ;;=^358.31IA^4^2
+235 ;;^UTILITY(U,$J,358.3,8069,1,3,0)
+236 ;;=3^Sleep Apnea,Obstructive
+237 ;;^UTILITY(U,$J,358.3,8069,1,4,0)
+238 ;;=4^G47.33
+239 ;;^UTILITY(U,$J,358.3,8069,2)
+240 ;;=^332763
+241 ;;^UTILITY(U,$J,358.3,8070,0)
+242 ;;=R73.01^^45^416^46
+243 ;;^UTILITY(U,$J,358.3,8070,1,0)
+244 ;;=^358.31IA^4^2
+245 ;;^UTILITY(U,$J,358.3,8070,1,3,0)
+246 ;;=3^Impaired Fasting Glucose
+247 ;;^UTILITY(U,$J,358.3,8070,1,4,0)
+248 ;;=4^R73.01
+249 ;;^UTILITY(U,$J,358.3,8070,2)
+250 ;;=^5019561
+251 ;;^UTILITY(U,$J,358.3,8071,0)
+252 ;;=R74.8^^45^416^1
+253 ;;^UTILITY(U,$J,358.3,8071,1,0)
+254 ;;=^358.31IA^4^2
+255 ;;^UTILITY(U,$J,358.3,8071,1,3,0)
+256 ;;=3^Abnormal Levels of Serum Enzymes
+257 ;;^UTILITY(U,$J,358.3,8071,1,4,0)
+258 ;;=4^R74.8
+259 ;;^UTILITY(U,$J,358.3,8071,2)
+260 ;;=^5019566
+261 ;;^UTILITY(U,$J,358.3,8072,0)
+262 ;;=R03.0^^45^416^27
+263 ;;^UTILITY(U,$J,358.3,8072,1,0)
+264 ;;=^358.31IA^4^2
+265 ;;^UTILITY(U,$J,358.3,8072,1,3,0)
+266 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
+267 ;;^UTILITY(U,$J,358.3,8072,1,4,0)
+268 ;;=4^R03.0
+269 ;;^UTILITY(U,$J,358.3,8072,2)
+270 ;;=^5019171
+271 ;;^UTILITY(U,$J,358.3,8073,0)
+272 ;;=Z91.19^^45^416^53
+273 ;;^UTILITY(U,$J,358.3,8073,1,0)
+274 ;;=^358.31IA^4^2
+275 ;;^UTILITY(U,$J,358.3,8073,1,3,0)
+276 ;;=3^Noncompliance w/ Medical Treatment/Regimen
+277 ;;^UTILITY(U,$J,358.3,8073,1,4,0)
+278 ;;=4^Z91.19
+279 ;;^UTILITY(U,$J,358.3,8073,2)
+280 ;;=^5063618
+281 ;;^UTILITY(U,$J,358.3,8074,0)
+282 ;;=E66.01^^45^416^54
+283 ;;^UTILITY(U,$J,358.3,8074,1,0)
+284 ;;=^358.31IA^4^2
+285 ;;^UTILITY(U,$J,358.3,8074,1,3,0)
+286 ;;=3^Obesity,Morbid
+287 ;;^UTILITY(U,$J,358.3,8074,1,4,0)
+288 ;;=4^E66.01
+289 ;;^UTILITY(U,$J,358.3,8074,2)
+290 ;;=^5002826
+291 ;;^UTILITY(U,$J,358.3,8075,0)
+292 ;;=F43.11^^45^416^61
+293 ;;^UTILITY(U,$J,358.3,8075,1,0)
+294 ;;=^358.31IA^4^2
+295 ;;^UTILITY(U,$J,358.3,8075,1,3,0)
+296 ;;=3^PTSD,Acute
+297 ;;^UTILITY(U,$J,358.3,8075,1,4,0)
+298 ;;=4^F43.11
+299 ;;^UTILITY(U,$J,358.3,8075,2)
+300 ;;=^5003571
+301 ;;^UTILITY(U,$J,358.3,8076,0)
+302 ;;=F43.12^^45^416^62
+303 ;;^UTILITY(U,$J,358.3,8076,1,0)
+304 ;;=^358.31IA^4^2
+305 ;;^UTILITY(U,$J,358.3,8076,1,3,0)
+306 ;;=3^PTSD,Chronic
+307 ;;^UTILITY(U,$J,358.3,8076,1,4,0)
+308 ;;=4^F43.12
+309 ;;^UTILITY(U,$J,358.3,8076,2)
+310 ;;=^5003572
+311 ;;^UTILITY(U,$J,358.3,8077,0)
+312 ;;=I25.119^^45^416^5
+313 ;;^UTILITY(U,$J,358.3,8077,1,0)
+314 ;;=^358.31IA^4^2
+315 ;;^UTILITY(U,$J,358.3,8077,1,3,0)
+316 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
+317 ;;^UTILITY(U,$J,358.3,8077,1,4,0)
+318 ;;=4^I25.119
+319 ;;^UTILITY(U,$J,358.3,8077,2)
+320 ;;=^5007111
+321 ;;^UTILITY(U,$J,358.3,8078,0)
+322 ;;=I25.10^^45^416^6
+323 ;;^UTILITY(U,$J,358.3,8078,1,0)
+324 ;;=^358.31IA^4^2
+325 ;;^UTILITY(U,$J,358.3,8078,1,3,0)
+326 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
+327 ;;^UTILITY(U,$J,358.3,8078,1,4,0)
+328 ;;=4^I25.10
+329 ;;^UTILITY(U,$J,358.3,8078,2)
+330 ;;=^5007107
+331 ;;^UTILITY(U,$J,358.3,8079,0)
+332 ;;=F17.219^^45^416^51
+333 ;;^UTILITY(U,$J,358.3,8079,1,0)
+334 ;;=^358.31IA^4^2
+335 ;;^UTILITY(U,$J,358.3,8079,1,3,0)
+336 ;;=3^Nicotine Dependence,Cigarettes
+337 ;;^UTILITY(U,$J,358.3,8079,1,4,0)
+338 ;;=4^F17.219
+339 ;;^UTILITY(U,$J,358.3,8079,2)
+340 ;;=^5003369
+341 ;;^UTILITY(U,$J,358.3,8080,0)
+342 ;;=Z51.5^^45^416^64
+343 ;;^UTILITY(U,$J,358.3,8080,1,0)
+344 ;;=^358.31IA^4^2
+345 ;;^UTILITY(U,$J,358.3,8080,1,3,0)
+346 ;;=3^Palliative Care Encounter
+347 ;;^UTILITY(U,$J,358.3,8080,1,4,0)
+348 ;;=4^Z51.5
+349 ;;^UTILITY(U,$J,358.3,8080,2)
+350 ;;=^5063063
+351 ;;^UTILITY(U,$J,358.3,8081,0)
+352 ;;=Z23.^^45^416^28
+353 ;;^UTILITY(U,$J,358.3,8081,1,0)
+354 ;;=^358.31IA^4^2
+355 ;;^UTILITY(U,$J,358.3,8081,1,3,0)
+356 ;;=3^Encounter for Immunization(s)
+357 ;;^UTILITY(U,$J,358.3,8081,1,4,0)
+358 ;;=4^Z23.
+359 ;;^UTILITY(U,$J,358.3,8081,2)
+360 ;;=^5062795
+361 ;;^UTILITY(U,$J,358.3,8082,0)
+362 ;;=E11.65^^45^416^20
+363 ;;^UTILITY(U,$J,358.3,8082,1,0)
+364 ;;=^358.31IA^4^2
+365 ;;^UTILITY(U,$J,358.3,8082,1,3,0)
+366 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
+367 ;;^UTILITY(U,$J,358.3,8082,1,4,0)
+368 ;;=4^E11.65
+369 ;;^UTILITY(U,$J,358.3,8082,2)
+370 ;;=^5002663
+371 ;;^UTILITY(U,$J,358.3,8083,0)
+372 ;;=E11.649^^45^416^21
+373 ;;^UTILITY(U,$J,358.3,8083,1,0)
+374 ;;=^358.31IA^4^2
+375 ;;^UTILITY(U,$J,358.3,8083,1,3,0)
+376 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
+377 ;;^UTILITY(U,$J,358.3,8083,1,4,0)
+378 ;;=4^E11.649
+379 ;;^UTILITY(U,$J,358.3,8083,2)
+380 ;;=^5002662
+381 ;;^UTILITY(U,$J,358.3,8084,0)
+382 ;;=I16.0^^45^416^44
+383 ;;^UTILITY(U,$J,358.3,8084,1,0)
+384 ;;=^358.31IA^4^2
+385 ;;^UTILITY(U,$J,358.3,8084,1,3,0)
+386 ;;=3^Hypertensive Urgency
+387 ;;^UTILITY(U,$J,358.3,8084,1,4,0)
+388 ;;=4^I16.0
+389 ;;^UTILITY(U,$J,358.3,8084,2)
+390 ;;=^8133013
+391 ;;^UTILITY(U,$J,358.3,8085,0)
+392 ;;=H54.8^^45^416^47
+393 ;;^UTILITY(U,$J,358.3,8085,1,0)
+394 ;;=^358.31IA^4^2
+395 ;;^UTILITY(U,$J,358.3,8085,1,3,0)
+396 ;;=3^Legal Blindness,USA Definition
+397 ;;^UTILITY(U,$J,358.3,8085,1,4,0)
+398 ;;=4^H54.8
+399 ;;^UTILITY(U,$J,358.3,8085,2)
+400 ;;=^5006369
+401 ;;^UTILITY(U,$J,358.3,8086,0)
+402 ;;=F10.10^^45^416^2
+403 ;;^UTILITY(U,$J,358.3,8086,1,0)
+404 ;;=^358.31IA^4^2
+405 ;;^UTILITY(U,$J,358.3,8086,1,3,0)
+406 ;;=3^Alcohol Abuse,Uncomplicated
+407 ;;^UTILITY(U,$J,358.3,8086,1,4,0)
+408 ;;=4^F10.10
+409 ;;^UTILITY(U,$J,358.3,8086,2)
+410 ;;=^5003068
+411 ;;^UTILITY(U,$J,358.3,8087,0)
+412 ;;=J30.9^^45^416^3
+413 ;;^UTILITY(U,$J,358.3,8087,1,0)
+414 ;;=^358.31IA^4^2
+415 ;;^UTILITY(U,$J,358.3,8087,1,3,0)
+416 ;;=3^Allergic Rhinitis,Unspec
+417 ;;^UTILITY(U,$J,358.3,8087,1,4,0)
+418 ;;=4^J30.9
+419 ;;^UTILITY(U,$J,358.3,8087,2)
+420 ;;=^5008205
+421 ;;^UTILITY(U,$J,358.3,8088,0)
+422 ;;=I48.0^^45^416^7
+423 ;;^UTILITY(U,$J,358.3,8088,1,0)
+424 ;;=^358.31IA^4^2
+425 ;;^UTILITY(U,$J,358.3,8088,1,3,0)
+426 ;;=3^Atrial Fibrillation Paroxysmal (PAF)
+427 ;;^UTILITY(U,$J,358.3,8088,1,4,0)
+428 ;;=4^I48.0
+429 ;;^UTILITY(U,$J,358.3,8088,2)
+430 ;;=^90473
+431 ;;^UTILITY(U,$J,358.3,8089,0)
+432 ;;=N18.1^^45^416^9
+433 ;;^UTILITY(U,$J,358.3,8089,1,0)
+434 ;;=^358.31IA^4^2
+435 ;;^UTILITY(U,$J,358.3,8089,1,3,0)
+436 ;;=3^CKD,Stage 1
+437 ;;^UTILITY(U,$J,358.3,8089,1,4,0)
+438 ;;=4^N18.1
+439 ;;^UTILITY(U,$J,358.3,8089,2)
+440 ;;=^5015602
+441 ;;^UTILITY(U,$J,358.3,8090,0)
+442 ;;=N18.2^^45^416^10
+443 ;;^UTILITY(U,$J,358.3,8090,1,0)
+444 ;;=^358.31IA^4^2
+445 ;;^UTILITY(U,$J,358.3,8090,1,3,0)
+446 ;;=3^CKD,Stage 2
+447 ;;^UTILITY(U,$J,358.3,8090,1,4,0)
+448 ;;=4^N18.2
+449 ;;^UTILITY(U,$J,358.3,8090,2)
+450 ;;=^5015603
+451 ;;^UTILITY(U,$J,358.3,8091,0)
+452 ;;=N18.4^^45^416^14
+453 ;;^UTILITY(U,$J,358.3,8091,1,0)
+454 ;;=^358.31IA^4^2
+455 ;;^UTILITY(U,$J,358.3,8091,1,3,0)
+456 ;;=3^CKD,Stage 4
+457 ;;^UTILITY(U,$J,358.3,8091,1,4,0)
+458 ;;=4^N18.4
+459 ;;^UTILITY(U,$J,358.3,8091,2)
+460 ;;=^5015605
+461 ;;^UTILITY(U,$J,358.3,8092,0)
+462 ;;=N18.5^^45^416^15
+463 ;;^UTILITY(U,$J,358.3,8092,1,0)
+464 ;;=^358.31IA^4^2
+465 ;;^UTILITY(U,$J,358.3,8092,1,3,0)
+466 ;;=3^CKD,Stage 5
+467 ;;^UTILITY(U,$J,358.3,8092,1,4,0)
+468 ;;=4^N18.5
+469 ;;^UTILITY(U,$J,358.3,8092,2)
+470 ;;=^5015606
+471 ;;^UTILITY(U,$J,358.3,8093,0)
+472 ;;=N18.6^^45^416^26
+473 ;;^UTILITY(U,$J,358.3,8093,1,0)
+474 ;;=^358.31IA^4^2
+475 ;;^UTILITY(U,$J,358.3,8093,1,3,0)
+476 ;;=3^ESRD
+477 ;;^UTILITY(U,$J,358.3,8093,1,4,0)
+478 ;;=4^N18.6
+479 ;;^UTILITY(U,$J,358.3,8093,2)
+480 ;;=^303986
+481 ;;^UTILITY(U,$J,358.3,8094,0)
+482 ;;=E11.22^^45^416^22
+483 ;;^UTILITY(U,$J,358.3,8094,1,0)
+484 ;;=^358.31IA^4^2
+485 ;;^UTILITY(U,$J,358.3,8094,1,3,0)
+486 ;;=3^DM Type 2 w/ CKD
+487 ;;^UTILITY(U,$J,358.3,8094,1,4,0)
+488 ;;=4^E11.22
+489 ;;^UTILITY(U,$J,358.3,8094,2)
+490 ;;=^5002630
+491 ;;^UTILITY(U,$J,358.3,8095,0)
+492 ;;=E11.319^^45^416^24
+493 ;;^UTILITY(U,$J,358.3,8095,1,0)
+494 ;;=^358.31IA^4^2
+495 ;;^UTILITY(U,$J,358.3,8095,1,3,0)
+496 ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
+497 ;;^UTILITY(U,$J,358.3,8095,1,4,0)
+498 ;;=4^E11.319
+499 ;;^UTILITY(U,$J,358.3,8095,2)
+500 ;;=^5002633
+501 ;;^UTILITY(U,$J,358.3,8096,0)
+502 ;;=G40.909^^45^416^76
+503 ;;^UTILITY(U,$J,358.3,8096,1,0)
+504 ;;=^358.31IA^4^2
+505 ;;^UTILITY(U,$J,358.3,8096,1,3,0)
+506 ;;=3^Seizure Disorder NOS
+507 ;;^UTILITY(U,$J,358.3,8096,1,4,0)
+508 ;;=4^G40.909
+509 ;;^UTILITY(U,$J,358.3,8096,2)
+510 ;;=^5003865
+511 ;;^UTILITY(U,$J,358.3,8097,0)
+512 ;;=N52.9^^45^416^30
+513 ;;^UTILITY(U,$J,358.3,8097,1,0)
+514 ;;=^358.31IA^4^2
+515 ;;^UTILITY(U,$J,358.3,8097,1,3,0)
+516 ;;=3^Erectile Dysfuntion,Unspec
+517 ;;^UTILITY(U,$J,358.3,8097,1,4,0)
+518 ;;=4^N52.9
+519 ;;^UTILITY(U,$J,358.3,8097,2)
+520 ;;=^5015763
+521 ;;^UTILITY(U,$J,358.3,8098,0)
+522 ;;=I50.22^^45^416^39
+523 ;;^UTILITY(U,$J,358.3,8098,1,0)
+524 ;;=^358.31IA^4^2
+525 ;;^UTILITY(U,$J,358.3,8098,1,3,0)
+526 ;;=3^Heart Failure,Systolic,Chronic
+527 ;;^UTILITY(U,$J,358.3,8098,1,4,0)
+528 ;;=4^I50.22
+529 ;;^UTILITY(U,$J,358.3,8098,2)
+530 ;;=^5007241
+531 ;;^UTILITY(U,$J,358.3,8099,0)
+532 ;;=I50.32^^45^416^37
+533 ;;^UTILITY(U,$J,358.3,8099,1,0)
+534 ;;=^358.31IA^4^2
+535 ;;^UTILITY(U,$J,358.3,8099,1,3,0)
+536 ;;=3^Heart Failure,Diastolic,Chronic
+537 ;;^UTILITY(U,$J,358.3,8099,1,4,0)
+538 ;;=4^I50.32
+539 ;;^UTILITY(U,$J,358.3,8099,2)
+540 ;;=^5007245
+541 ;;^UTILITY(U,$J,358.3,8100,0)
+542 ;;=I50.42^^45^416^38
+543 ;;^UTILITY(U,$J,358.3,8100,1,0)
+544 ;;=^358.31IA^4^2
+545 ;;^UTILITY(U,$J,358.3,8100,1,3,0)
+546 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
+547 ;;^UTILITY(U,$J,358.3,8100,1,4,0)
+548 ;;=4^I50.42
+549 ;;^UTILITY(U,$J,358.3,8100,2)
+550 ;;=^5007249
+551 ;;^UTILITY(U,$J,358.3,8101,0)
+552 ;;=I13.0^^45^416^32
+553 ;;^UTILITY(U,$J,358.3,8101,1,0)
+554 ;;=^358.31IA^4^2
+555 ;;^UTILITY(U,$J,358.3,8101,1,3,0)
+556 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
+557 ;;^UTILITY(U,$J,358.3,8101,1,4,0)
+558 ;;=4^I13.0
+559 ;;^UTILITY(U,$J,358.3,8101,2)
+560 ;;=^5007067
+561 ;;^UTILITY(U,$J,358.3,8102,0)
+562 ;;=I13.2^^45^416^33
+563 ;;^UTILITY(U,$J,358.3,8102,1,0)
+564 ;;=^358.31IA^4^2
+565 ;;^UTILITY(U,$J,358.3,8102,1,3,0)
+566 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
+567 ;;^UTILITY(U,$J,358.3,8102,1,4,0)
+568 ;;=4^I13.2
+569 ;;^UTILITY(U,$J,358.3,8102,2)
+570 ;;=^5007070
+571 ;;^UTILITY(U,$J,358.3,8103,0)
+572 ;;=I13.10^^45^416^34
+573 ;;^UTILITY(U,$J,358.3,8103,1,0)
+574 ;;=^358.31IA^4^2
+575 ;;^UTILITY(U,$J,358.3,8103,1,3,0)
+576 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
+577 ;;^UTILITY(U,$J,358.3,8103,1,4,0)
+578 ;;=4^I13.10
+579 ;;^UTILITY(U,$J,358.3,8103,2)
+580 ;;=^5007068
+581 ;;^UTILITY(U,$J,358.3,8104,0)
+582 ;;=I13.11^^45^416^35
+583 ;;^UTILITY(U,$J,358.3,8104,1,0)
+584 ;;=^358.31IA^4^2
+585 ;;^UTILITY(U,$J,358.3,8104,1,3,0)
+586 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
+587 ;;^UTILITY(U,$J,358.3,8104,1,4,0)
+588 ;;=4^I13.11
+589 ;;^UTILITY(U,$J,358.3,8104,2)
+590 ;;=^5007069
+591 ;;^UTILITY(U,$J,358.3,8105,0)
+592 ;;=E03.9^^45^416^45
+593 ;;^UTILITY(U,$J,358.3,8105,1,0)
+594 ;;=^358.31IA^4^2
+595 ;;^UTILITY(U,$J,358.3,8105,1,3,0)
+596 ;;=3^Hypothyroidism,Unspec
+597 ;;^UTILITY(U,$J,358.3,8105,1,4,0)
+598 ;;=4^E03.9
+599 ;;^UTILITY(U,$J,358.3,8105,2)
+600 ;;=^5002476
+601 ;;^UTILITY(U,$J,358.3,8106,0)
+602 ;;=C61.^^45^416^49
+603 ;;^UTILITY(U,$J,358.3,8106,1,0)
+604 ;;=^358.31IA^4^2
+605 ;;^UTILITY(U,$J,358.3,8106,1,3,0)
+606 ;;=3^Malig Neopl Prostate
+607 ;;^UTILITY(U,$J,358.3,8106,1,4,0)
+608 ;;=4^C61.
+609 ;;^UTILITY(U,$J,358.3,8106,2)
+610 ;;=^267239
+611 ;;^UTILITY(U,$J,358.3,8107,0)
+612 ;;=F11.20^^45^416^55
+613 ;;^UTILITY(U,$J,358.3,8107,1,0)
+614 ;;=^358.31IA^4^2
+615 ;;^UTILITY(U,$J,358.3,8107,1,3,0)
+616 ;;=3^Opioid Dependence,Uncomplicated
+617 ;;^UTILITY(U,$J,358.3,8107,1,4,0)
+618 ;;=4^F11.20
+619 ;;^UTILITY(U,$J,358.3,8107,2)
+620 ;;=^5003127
+621 ;;^UTILITY(U,$J,358.3,8108,0)
+622 ;;=M19.90^^45^416^56
+623 ;;^UTILITY(U,$J,358.3,8108,1,0)
+624 ;;=^358.31IA^4^2
+625 ;;^UTILITY(U,$J,358.3,8108,1,3,0)
+626 ;;=3^Osteoarthritis,Unspec
+627 ;;^UTILITY(U,$J,358.3,8108,1,4,0)
+628 ;;=4^M19.90
+629 ;;^UTILITY(U,$J,358.3,8108,2)
+630 ;;=^5010853
+631 ;;^UTILITY(U,$J,358.3,8109,0)
+632 ;;=M85.80^^45^416^57
+633 ;;^UTILITY(U,$J,358.3,8109,1,0)
+634 ;;=^358.31IA^4^2
+635 ;;^UTILITY(U,$J,358.3,8109,1,3,0)
+636 ;;=3^Osteopenia,Unspec Site
+637 ;;^UTILITY(U,$J,358.3,8109,1,4,0)
+638 ;;=4^M85.80
+639 ;;^UTILITY(U,$J,358.3,8109,2)
+640 ;;=^5014473
+641 ;;^UTILITY(U,$J,358.3,8110,0)
+642 ;;=M81.0^^45^416^58
+643 ;;^UTILITY(U,$J,358.3,8110,1,0)
+644 ;;=^358.31IA^4^2
+645 ;;^UTILITY(U,$J,358.3,8110,1,3,0)
+646 ;;=3^Osteoporosis,Age-Related w/o Fx
+647 ;;^UTILITY(U,$J,358.3,8110,1,4,0)
+648 ;;=4^M81.0
+649 ;;^UTILITY(U,$J,358.3,8110,2)
+650 ;;=^5013555
+651 ;;^UTILITY(U,$J,358.3,8111,0)
+652 ;;=I73.9^^45^416^65
+653 ;;^UTILITY(U,$J,358.3,8111,1,0)
+654 ;;=^358.31IA^4^2
+655 ;;^UTILITY(U,$J,358.3,8111,1,3,0)
+656 ;;=3^Peripheral Vascular Disease,Unspec
+657 ;;^UTILITY(U,$J,358.3,8111,1,4,0)
+658 ;;=4^I73.9
+659 ;;^UTILITY(U,$J,358.3,8111,2)
+660 ;;=^184182
+661 ;;^UTILITY(U,$J,358.3,8112,0)
+662 ;;=R21.^^45^416^68
+663 ;;^UTILITY(U,$J,358.3,8112,1,0)
+664 ;;=^358.31IA^4^2
+665 ;;^UTILITY(U,$J,358.3,8112,1,3,0)
+666 ;;=3^Rash
+667 ;;^UTILITY(U,$J,358.3,8112,1,4,0)
+668 ;;=4^R21.
+669 ;;^UTILITY(U,$J,358.3,8112,2)
+670 ;;=^5019283
+671 ;;^UTILITY(U,$J,358.3,8113,0)
+672 ;;=Z12.11^^45^416^73
+673 ;;^UTILITY(U,$J,358.3,8113,1,0)
+674 ;;=^358.31IA^4^2
+675 ;;^UTILITY(U,$J,358.3,8113,1,3,0)
+676 ;;=3^Screening,Colon CA
+677 ;;^UTILITY(U,$J,358.3,8113,1,4,0)
+678 ;;=4^Z12.11
+679 ;;^UTILITY(U,$J,358.3,8113,2)
+680 ;;=^5062681
+681 ;;^UTILITY(U,$J,358.3,8114,0)
+682 ;;=Z12.39^^45^416^71
+683 ;;^UTILITY(U,$J,358.3,8114,1,0)
+684 ;;=^358.31IA^4^2
+685 ;;^UTILITY(U,$J,358.3,8114,1,3,0)
+686 ;;=3^Screening,Breast CA
+687 ;;^UTILITY(U,$J,358.3,8114,1,4,0)
+688 ;;=4^Z12.39
+689 ;;^UTILITY(U,$J,358.3,8114,2)
+690 ;;=^5062686
+691 ;;^UTILITY(U,$J,358.3,8115,0)
+692 ;;=Z12.4^^45^416^72
+693 ;;^UTILITY(U,$J,358.3,8115,1,0)
+694 ;;=^358.31IA^4^2
+695 ;;^UTILITY(U,$J,358.3,8115,1,3,0)
+696 ;;=3^Screening,Cervical CA
+697 ;;^UTILITY(U,$J,358.3,8115,1,4,0)
+698 ;;=4^Z12.4
+699 ;;^UTILITY(U,$J,358.3,8115,2)
+700 ;;=^5062687
+701 ;;^UTILITY(U,$J,358.3,8116,0)
+702 ;;=Z13.6^^45^416^70
+703 ;;^UTILITY(U,$J,358.3,8116,1,0)
+704 ;;=^358.31IA^4^2
+705 ;;^UTILITY(U,$J,358.3,8116,1,3,0)
+706 ;;=3^Screening,AAA
+707 ;;^UTILITY(U,$J,358.3,8116,1,4,0)
+708 ;;=4^Z13.6
+709 ;;^UTILITY(U,$J,358.3,8116,2)
+710 ;;=^5062707
+711 ;;^UTILITY(U,$J,358.3,8117,0)
+712 ;;=Z11.3^^45^416^75
+713 ;;^UTILITY(U,$J,358.3,8117,1,0)
+714 ;;=^358.31IA^4^2
